WHO Option B+: Early Experience of Antiretroviral Therapy Sequencing after Cessation of Breastfeeding and Risk of Dermatologic Toxicity.

ArticleinJAIDS Journal of Acquired Immune Deficiency Syndromes 62(3):e101-e103 · March 2013with45 Reads
Impact Factor: 4.56 · DOI: 10.1097/QAI.0b013e31828011ca · Source: PubMed